{
    "General": {
        "Code": "0A9G",
        "Type": "Common Stock",
        "Name": "Mereo BioPharma Group PLC ADR",
        "Exchange": "LSE",
        "CurrencyCode": "USD",
        "CurrencyName": "US Dollar",
        "CurrencySymbol": "$",
        "CountryName": "UK",
        "CountryISO": "GB",
        "OpenFigi": null,
        "ExchangeMarket": null,
        "ISIN": null,
        "LEI": null,
        "PrimaryTicker": null,
        "CIK": null,
        "EmployerIdNumber": null,
        "FiscalYearEnd": "December",
        "IPODate": null,
        "InternationalDomestic": null,
        "Sector": "",
        "Industry": "",
        "GicSector": "Industrials",
        "GicGroup": "Commercial & Professional Services",
        "GicIndustry": "Commercial Services & Supplies",
        "GicSubIndustry": "Environmental & Facilities Services",
        "Description": "Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumors. The company is also developing Navicixizumab (OMP-305B83), which has completed Phase 1b clinical trials for the treatment of the late line ovarian cancer; Acumapimod (BCT-197), a p38 MAP kinase inhibitor that is in Phase II clinical trials to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole (BGS-649), an oral aromatase inhibitor for the treatment of hypogonadotropic hypogonadism which is in Phase 2 trials. In addition, it develops rare disease product candidates, including Setrusumab (BPS-804), a novel antibody for the treatment of osteogenesis imperfecta; and Alvelestat (MPH-966), an oral small molecule that is in Phase II clinical trial to treat Alpha-1 anti-trypsin deficiency. The company has a collaboration with The University of Texas MD Anderson Cancer Center to evaluate anti-TIGIT therapeutic antibody candidate, etigilimab; and license agreement with Ultragenyx Pharmaceutical Inc. to develop and commercialize setrusumab. Mereo BioPharma Group plc was incorporated in 2015 and is headquartered in London, the United Kingdom.",
        "Address": "One Cavendish Place, London, United Kingdom, W1G 0QF",
        "AddressData": {
            "Street": "One Cavendish Place",
            "City": "London",
            "Country": "United Kingdom",
            "ZIP": "W1G 0QF"
        },
        "Listings": {},
        "Officers": {
            "0": {
                "Name": "Dr. Denise  Scots-Knight Ph.D.",
                "Title": "Co-Founder, CEO & Exec. Director",
                "YearBorn": "1959"
            },
            "1": {
                "Name": "Mr. Charles  Sermon",
                "Title": "Co-Founder, Gen. Counsel & Company Sec.",
                "YearBorn": "1969"
            },
            "2": {
                "Name": "Dr. Alastair  MacKinnon M.D., MBBS",
                "Title": "Co-Founder and Chief of Portfolio & Pipeline Strategy",
                "YearBorn": "1970"
            },
            "3": {
                "Name": "Dr. John P. Richard M.B.A., MBA",
                "Title": "Co-Founder & Chief Bus. Officer",
                "YearBorn": "1957"
            },
            "4": {
                "Name": "Ms. Christine  Fox CPA",
                "Title": "Chief Financial Officer",
                "YearBorn": "1981"
            },
            "5": {
                "Name": "Dr. John A. Lewicki Ph.D.",
                "Title": "Chief Scientific Officer",
                "YearBorn": "1952"
            },
            "6": {
                "Name": "Dr. Jackie  Parkin",
                "Title": "Therapy Area Head of Respiratory Endocrinology",
                "YearBorn": "NA"
            },
            "7": {
                "Name": "Ms. Alexandra  Hughes-Wilson",
                "Title": "Chief of Patient Access & Commercial Planning",
                "YearBorn": "1971"
            },
            "8": {
                "Name": "Dr. Suba  Krishnan",
                "Title": "Sr. VP of Clinical Devel.",
                "YearBorn": "NA"
            },
            "9": {
                "Name": "Dr. Fiona  Bor",
                "Title": "Head of Intellectual Property",
                "YearBorn": "NA"
            }
        },
        "Phone": "44 33 3023 7300",
        "WebURL": "https://www.mereobiopharma.com",
        "LogoURL": "",
        "FullTimeEmployees": 36,
        "UpdatedAt": "2023-09-03"
    },
    "Highlights": {
        "MarketCapitalization": null,
        "MarketCapitalizationMln": null,
        "EBITDA": -43425000,
        "PERatio": null,
        "PEGRatio": null,
        "WallStreetTargetPrice": 4.38,
        "BookValue": 0.496,
        "DividendShare": 0,
        "DividendYield": 0,
        "EarningsShare": -0.285,
        "EPSEstimateCurrentYear": 0,
        "EPSEstimateNextYear": 0,
        "EPSEstimateNextQuarter": 0,
        "EPSEstimateCurrentQuarter": 0,
        "MostRecentQuarter": "2022-12-31",
        "ProfitMargin": 0,
        "OperatingMarginTTM": 0,
        "ReturnOnAssetsTTM": -0.2539,
        "ReturnOnEquityTTM": -0.4563,
        "RevenueTTM": 0,
        "RevenuePerShareTTM": 0,
        "QuarterlyRevenueGrowthYOY": 0,
        "GrossProfitTTM": 936000,
        "DilutedEpsTTM": -0.285,
        "QuarterlyEarningsGrowthYOY": 0
    },
    "Valuation": {
        "TrailingPE": 0,
        "ForwardPE": 0,
        "PriceSalesTTM": 0,
        "PriceBookMRQ": 0,
        "EnterpriseValue": 146190832,
        "EnterpriseValueRevenue": 0,
        "EnterpriseValueEbitda": 0
    },
    "SharesStats": {
        "SharesOutstanding": 0,
        "SharesFloat": 75303234,
        "PercentInsiders": 0,
        "PercentInstitutions": 51.099000000000004,
        "SharesShort": null,
        "SharesShortPriorMonth": null,
        "ShortRatio": null,
        "ShortPercentOutstanding": null,
        "ShortPercentFloat": null
    },
    "Technicals": {
        "Beta": 0.9232,
        "52WeekHigh": 1.7412,
        "52WeekLow": 0.5354,
        "50DayMA": 1.3028,
        "200DayMA": 1.0939,
        "SharesShort": 0,
        "SharesShortPriorMonth": 0,
        "ShortRatio": 0,
        "ShortPercent": 0
    },
    "SplitsDividends": {
        "ForwardAnnualDividendRate": 0,
        "ForwardAnnualDividendYield": 0,
        "PayoutRatio": 0,
        "DividendDate": "0000-00-00",
        "ExDividendDate": "0000-00-00",
        "LastSplitFactor": "",
        "LastSplitDate": "0000-00-00",
        "NumberDividendsByYear": {}
    },
    "Holders": null,
    "InsiderTransactions": {},
    "outstandingShares": {
        "annual": {},
        "quarterly": {}
    },
    "Earnings": {
        "History": {
            "2024-03-31": {
                "reportDate": "2024-05-21",
                "date": "2024-03-31",
                "beforeAfterMarket": "AfterMarket",
                "currency": null,
                "epsActual": null,
                "epsEstimate": null,
                "epsDifference": null,
                "surprisePercent": null
            },
            "2023-12-31": {
                "reportDate": "2024-02-20",
                "date": "2023-12-31",
                "beforeAfterMarket": "AfterMarket",
                "currency": null,
                "epsActual": null,
                "epsEstimate": null,
                "epsDifference": null,
                "surprisePercent": null
            },
            "2023-09-30": {
                "reportDate": "2023-11-17",
                "date": "2023-09-30",
                "beforeAfterMarket": "AfterMarket",
                "currency": null,
                "epsActual": null,
                "epsEstimate": null,
                "epsDifference": null,
                "surprisePercent": null
            }
        },
        "Trend": {
            "2020-12-31": {
                "date": "2020-12-31",
                "period": "+1y",
                "growth": null,
                "earningsEstimateAvg": "0.0000",
                "earningsEstimateLow": "0.0000",
                "earningsEstimateHigh": "0.0000",
                "earningsEstimateYearAgoEps": null,
                "earningsEstimateNumberOfAnalysts": "0.0000",
                "earningsEstimateGrowth": null,
                "revenueEstimateAvg": "0.00",
                "revenueEstimateLow": "4400000.00",
                "revenueEstimateHigh": "4400000.00",
                "revenueEstimateYearAgoEps": null,
                "revenueEstimateNumberOfAnalysts": "1.00",
                "revenueEstimateGrowth": null,
                "epsTrendCurrent": "0.0000",
                "epsTrend7daysAgo": "-52.0000",
                "epsTrend30daysAgo": "-52.0000",
                "epsTrend60daysAgo": "-52.0000",
                "epsTrend90daysAgo": "-52.0000",
                "epsRevisionsUpLast7days": "0.0000",
                "epsRevisionsUpLast30days": "0.0000",
                "epsRevisionsDownLast7days": null,
                "epsRevisionsDownLast30days": "0.0000"
            },
            "2020-03-31": {
                "date": "2020-03-31",
                "period": "+1q",
                "growth": null,
                "earningsEstimateAvg": "0.0000",
                "earningsEstimateLow": "0.0000",
                "earningsEstimateHigh": "0.0000",
                "earningsEstimateYearAgoEps": null,
                "earningsEstimateNumberOfAnalysts": "0.0000",
                "earningsEstimateGrowth": null,
                "revenueEstimateAvg": "0.00",
                "revenueEstimateLow": "0.00",
                "revenueEstimateHigh": "0.00",
                "revenueEstimateYearAgoEps": null,
                "revenueEstimateNumberOfAnalysts": "0.00",
                "revenueEstimateGrowth": null,
                "epsTrendCurrent": "0.0000",
                "epsTrend7daysAgo": "0.0000",
                "epsTrend30daysAgo": "0.0000",
                "epsTrend60daysAgo": "0.0000",
                "epsTrend90daysAgo": "0.0000",
                "epsRevisionsUpLast7days": "0.0000",
                "epsRevisionsUpLast30days": "0.0000",
                "epsRevisionsDownLast7days": null,
                "epsRevisionsDownLast30days": "0.0000"
            },
            "2019-12-31": {
                "date": "2019-12-31",
                "period": "0y",
                "growth": null,
                "earningsEstimateAvg": "0.0000",
                "earningsEstimateLow": "0.0000",
                "earningsEstimateHigh": "0.0000",
                "earningsEstimateYearAgoEps": null,
                "earningsEstimateNumberOfAnalysts": "0.0000",
                "earningsEstimateGrowth": null,
                "revenueEstimateAvg": "0.00",
                "revenueEstimateLow": "0.00",
                "revenueEstimateHigh": "0.00",
                "revenueEstimateYearAgoEps": null,
                "revenueEstimateNumberOfAnalysts": "1.00",
                "revenueEstimateGrowth": null,
                "epsTrendCurrent": "0.0000",
                "epsTrend7daysAgo": "-0.4700",
                "epsTrend30daysAgo": "-0.4700",
                "epsTrend60daysAgo": "-0.4700",
                "epsTrend90daysAgo": "-0.4700",
                "epsRevisionsUpLast7days": "1.0000",
                "epsRevisionsUpLast30days": "1.0000",
                "epsRevisionsDownLast7days": null,
                "epsRevisionsDownLast30days": "0.0000"
            }
        },
        "Annual": {}
    },
    "Financials": {
        "Balance_Sheet": {
            "currency_symbol": null,
            "quarterly": {},
            "yearly": {}
        },
        "Cash_Flow": {
            "currency_symbol": null,
            "quarterly": {},
            "yearly": {}
        },
        "Income_Statement": {
            "currency_symbol": null,
            "quarterly": {},
            "yearly": {}
        }
    }
}